Guangzhou Lupeng Pharmaceutical Company Ltd.

This Phase 3 trial tests a new drug called rocbrutinib against other targeted therapies for mantle cell lymphoma, a type of blood cancer. About 394 adults whose cancer has returned or not responded to previous treatment will be randomly assigned to receive rocbrutinib or another …

This study tests a new drug called rocbrutinib alone against standard treatments for a specific, aggressive type of lymphoma (non-GCB DLBCL) that has returned or not responded to prior therapy. About 150 adults will be randomly assigned to receive either rocbrutinib or a standard…

This early-stage trial is testing an experimental drug called LP-168, taken as a pill, in adults with B-cell lymphoma that has come back or not responded to standard treatments. The study aims to find the safest dose and check for side effects in about 200 participants. It is too…

This early-stage study looks at how two common drugs—itraconazole (a fungus treatment) and rifampin (an antibiotic)—change the way the body processes rocbrutinib, an experimental medicine. About 28 healthy adults will take rocbrutinib alone and then with each other drug to measur…